Le corps de Lewy, marqueur abusif de la maladie de Parkinson ?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Bulletin De L Academie Nationale De Medecine

• Publication date

  2003-02-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S0001-4079(19)34049-X
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

  2006cited by this paper
• Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease

  2004cited by this paper
• Amygdala pathology in Parkinson's disease

  2004cited by this paper
• Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.

  2002cited by this paper
• Parkinson’s disease and sleepiness: An integral part of PD

  2002cited by this paper
• Cognitive impairments in advanced PD without dementia

  2002cited by this paper
• Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.

  2002cited by this paper
• Where Does Parkinson Disease Pathology Begin in the Brain?

  2002cited by this paper
• Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies.

  2001cited by this paper
• Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson’s disease

  2000cited by this paper
• Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

  2000cited by this paper
• A Drosophila model of Parkinson's disease

  2000cited by this paper
• A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease

  2000cited by this paper
• Dementia with Lewy bodies: a pure case.

  2000cited by this paper
• MPTP induces alpha‐synuclein aggregation in the substantia nigra of baboons

  2000cited by this paper
• Morphological substrates of mental dysfunction in Lewy body disease: an update.

  2000cited by this paper
• Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease

  2000cited by this paper
• Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt–Jakob disease

  2000cited by this paper
• Hallucinations, REM sleep, and Parkinson’s disease

  2000cited by this paper
• Neuritic degeneration in the hippocampus and amygdala in Parkinson’s disease in relation to Alzheimer pathology

  1999cited by this paper
• The occurrence of depressive symptoms in the preclinical phase of AD

  1999cited by this paper
• Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by α-synuclein immunocytochemistry

  1999cited by this paper
• The Proteasome, a Novel Protease Regulated by Multiple Mechanisms*

  1999cited by this paper
• Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease

  1999cited by this paper
• Report of the second dementia with Lewy body international workshop

  1999cited by this paper
• Clinical and quantitative pathologic correlates of dementia with Lewy bodies

  1999cited by this paper
• Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups.

  1999cited by this paper
• Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease

  1999cited by this paper
• Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?

  1999cited by this paper
• Axonal transport of synucleins is mediated by all rate components

  1999cited by this paper
• Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson’s disease

  1998cited by this paper
• Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

  1998cited by this paper
• Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

  1998cited by this paper
• Apolipoprotein E4 in Parkinson Disease and Dementia: New Data and Meta‐Analysis of Published Studies

  1998cited by this paper
• Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?

  1998cited by this paper
• α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

  1998cited by this paper
• Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

  1998cited by this paper
• Close relationship between spongiform change and ubiquitin-positive granular structures in diffuse Lewy body disease.

  1997cited by this paper
• Amyloid ß-peptide and its relationship with dementia in Lewy body disease

  1997cited by this paper
• Neuropathological Assessment of Alzheimer's Disease: The Experience of the Consortium to Establish a Registry for Alzheimer's Disease

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

  1997cited by this paper
• Immunocytochemical Co‐localization of the Proteasome in Ubiquitinated Structures in Neurodegenerative Diseases and the Elderly

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.

  1996cited by this paper
• Lewy body dysphagia.

  1995cited by this paper
• Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

  1995cited by this paper
• Neuropathologic Evidence that the Lewy Body Variant of Alzheimer Disease Represents Coexistence of Alzheimer Disease and Idiopathic Parkinson Disease

  1995cited by this paper
• Alzheimer's disease with and without coexisting Parkinson's disease changes

  1995cited by this paper
• A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease

  1994cited by this paper
• Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene.

  1994cited by this paper
• A clinicopathologic study of 100 cases of Parkinson's disease.

  1993cited by this paper
• Pathology and Biology of the Lewy Body

  1993cited by this paper
• Dementia and neuropathology in Lewy body disease.

  1993cited by this paper
• The locus ceruleus and dementia in Parkinson's disease

  1993cited by this paper
• Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

  1993cited by this paper
• Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa

  1993cited by this paper
• Operational criteria for senile dementia of Lewy body type (SDLT)

  1992cited by this paper
• Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease

  1991cited by this paper
• Epitopes located in spatially separate domains of each neurofilament subunit are present in parkinson's disease lewy bodies

  1991cited by this paper
• Diffuse lewy body disease in Japan

  1990cited by this paper
• Senile dementia of Lewy body type: A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

  1990cited by this paper
• The Lewy body variant of Alzheimer's disease

  1990cited by this paper
• Lewy Bodies in Alzheimer Disease‐One or Two Diseases?

  1989cited by this paper
• THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE

  1989cited by this paper
• Prevalence of lewy bodies in alzheimer's disease

  1989cited by this paper
• Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

  1989cited by this paper
• Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

  1988cited by this paper
• The basal nucleus of Meynert in idiopathic Parkinson's disease

  1984cited by this paper
• Dementia in idiopathic Parkinson's disease

  1984cited by this paper
• Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree--a new disease?

  1984cited by this paper
• Is the mesocortical dopaminergic system involved in Parkinson disease?

  1980cited by this paper
• Dementia in Parkinson disease

  1979cited by this paper
• Dementia in Parkinson disease

  1979cited by this paper
• Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra and Locus Caeruleus in Parkinson's Disease

  1965cited by this paper
• DIFFUSE INTRACYTOPLASMIC GANGLIONIC INCLUSIONS (LEWY TYPE) ASSOCIATED WITH PROGRESSIVE DEMENTIA AND QUADRIPARESIS IN FLEXION

  1961cited by this paper
• Die Lehre vom Tonus und der Bewegung : Zugleich systematische Untersuchungen zur Klinik, Physiologie, Pathologie und Pathogenese der paralysis Agitans

  year unknowncited by this paper

• Les inclusions intracellulaires sont-elles toujours des témoins d'un trouble de la protéolyse intracellulaire ?

  2012cites this paper
• [The neuropathology of sleep in human neurodegenerative diseases].

  2008cites this paper